Your browser doesn't support javascript.
loading
Novel Imaging Technologies for Accurate Assessment of Cardiac Allograft Performance.
Higuita, Manuela Lopera; Jain, Rohil; Osho, Asishana A; Rabi, S Alireza; Pruett, Timothy L; Pierson, Richard N; Iaizzo, Paul A; Tessier, Shannon N.
Affiliation
  • Higuita ML; Center for Engineering in Medicine and Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Jain R; Shriners Hospitals for Children, Boston, MA, USA.
  • Osho AA; Center for Engineering in Medicine and Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Rabi SA; Shriners Hospitals for Children, Boston, MA, USA.
  • Pruett TL; Division of Cardiac Surgery, Corrigan Minehan Heart Center, Massachusetts General Hospital, MA, Boston, USA.
  • Pierson RN; Division of Cardiac Surgery, Corrigan Minehan Heart Center, Massachusetts General Hospital, MA, Boston, USA.
  • Iaizzo PA; Division of Solid Organ Transplantation and Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Tessier SN; Department of Surgery and Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Curr Transplant Rep ; 10(3): 100-109, 2023 Sep.
Article in En | MEDLINE | ID: mdl-39015560
ABSTRACT
Purpose of the Review The current lack of objective and quantitative assessment techniques to determine cardiac graft relative viability results in risk-averse decision-making, which negatively impact the utilization of cardiac grafts. The purpose of this review is to highlight the current deficiencies in cardiac allograft assessment before focusing on novel cardiac assessment techniques that exploit conventional and emerging imaging modalities, including ultrasound, magnetic resonance, and spectroscopy. Recent

Findings:

Extensive work is ongoing by the scientific community to identify improved objective metrics and tools for cardiac graft assessment, with the goal to safely increasing the number and proportion of hearts accepted for transplantation.

Summary:

This review briefly discusses the in situ and ex vivo tools currently available for clinical organ assessment, before focusing on the individual capabilities of ultrasound, magnetic resonance, and spectroscopy to provide insightful, non-invasive information regarding cardiac graft functional and metabolic status that may be used to predict outcome after transplantation.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Transplant Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Transplant Rep Year: 2023 Document type: Article